0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Nanoplastics Policy & Risk Remediation Sign in to save

Micro- and Nanoplastic-Induced Respiratory Disease and Dysfunction: A Scoping Review

Microplastics 2025 Score: 48 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Adrián Goldsworthy, Liam O’Callaghan, Oystein Tronstad, Jacky Y. Suen, H.-Y. Chen, Cassandra Rauert, C Blum, Lotti Tajouri, Matthew Olsen, Kevin V. Thomas, John F. Fraser

Summary

A systematic scoping review of 68 studies found that inhaled micro- and nanoplastics are detected in human lung tissue and associated with pulmonary inflammation, fibrosis, and impaired lung function, though most evidence comes from occupational settings and in vitro experiments.

Body Systems

Background: Human bioaccumulation of micro- and nanoplastics (MNPs) is increasingly being recognised in the aetiology and pathophysiology of human disease. This systematic scoping review aims to provide a comprehensive investigation of studies examining the presence and effects of MNPs on the human pulmonary system. Methods: A scoping review was conducted in line with JBI guidelines. Five databases (PubMed, SCOPUS, CINAHL, Web of Science and EMBASE) were systematically searched. Results: Sixty-eight articles were identified, with fifteen reporting the presence of MNPs in human respiratory tissues and fluids. The data reported in the remaining toxicology-focused studies suggest that MNPs induce widespread cellular dysfunction in pulmonary-related human cell lines. Exposure to MNPs was associated with significant cytotoxicity, genotoxicity and altered metabolic activity, including mitochondrial damage, increased reactive oxygen species and reduced membrane potential. Functionalised and smaller particles had more pronounced effects. Conclusions: The reported presence of MNPs, coupled with their biological toxicity, represents a growing global health concern. Evidence suggests MNPs may contribute to the rising burden of pulmonary disease worldwide, including cancer, COPD, interstitial lung disease and ARDS. Urgent international research is needed to characterise exposure pathways, develop standardised detection methods and understand the long-term health implications of MNP inhalation across the lifespan.

Sign in to start a discussion.

More Papers Like This

Systematic Review Tier 1

Deleterious effects of microplastics and nanoplastics on rodent lungs: a systematic review

This systematic review summarizes research on how inhaled micro- and nanoplastics affect the lungs in animal studies. The findings show these particles can cause lung inflammation, tissue damage, and immune responses, suggesting that breathing in airborne microplastics may pose real risks to respiratory health.

Article Tier 2

Microplastic and plastic pollution: impact on respiratory disease and health

This review pulls together evidence from lab studies, animal experiments, and workplace exposure research showing that inhaled micro- and nanoplastics can affect lung tissue and may contribute to respiratory diseases. However, the authors stress that it remains unclear how much damage occurs at the levels of plastic particles people actually breathe in daily life, highlighting the need for better measurements of real-world exposure.

Article Tier 2

Micro- and Nanoplastics and Pulmonary Health: The Current State of Research

This review evaluates the effects of micro- and nanoplastics on the respiratory system, noting that human autopsy studies confirm these particles are retained in lung tissue. Researchers examined how inhaled plastic particles may induce respiratory inflammation, oxidative stress, and other pulmonary effects. The study highlights that while airborne microplastics are a growing concern, our understanding of their short- and long-term impacts on lung health remains limited.

Article Tier 2

Respiratory Toxicity of Microplastics: Mechanisms, Clinical Outcomes, and Future Threats

This review summarized the respiratory toxicity of airborne microplastics, covering their sources, the routes by which they penetrate deep into lung tissue, and the range of clinical outcomes from chronic inflammation to potential malignancy. The authors warn that inhalation exposure represents an underappreciated and growing public health threat.

Article Tier 2

Respiratory Toxicity of Microplastics: Mechanisms, Clinical Outcomes, and Future Threats

This review examined the mechanisms by which inhaled airborne microplastics cause respiratory harm, including inflammation, oxidative stress, fibrosis, and impaired mucociliary clearance. The authors also discuss emerging evidence linking microplastic inhalation to worsening asthma, COPD, and potentially lung cancer.

Share this paper